Mass Photometry sheds light on the binding mechanism of the bispecific tetravalent anti-VEGF-PD-1 antibody Ivonescimab

In this webinar, we will show how we used mass photometry, a single molecule imaging technique capable of detecting biomolecular complexes in solution, to characterize ivonescimab’s binding behaviour with VEGF and PD-1. Join to discover how mass photometry can advance design of the next generation of therapeutic bispecific antibodies, with rapid and quantitative insight into dynamic, complex, and multi-target antigen interactions.

• Enabling rapid assessment of antigen and antibody quality
• Tracking complex formation and dynamics in real time
• Assessing antibody-antigen binding mechanisms in solution from nM concentration samples